AstraZeneca Pharma gets DCGI nod to market asthma drug

AstraZeneca Pharma gets DCGI nod to market asthma drug

NEW DELHI: Drug firm AstraZeneca Pharma on Monday said it has received marketing authorisation from Drug Controller General of India for Benralizumab solution, indicated as an add-on maintenance treatment for severe asthma. AstraZeneca Pharma India Ltd has received...